 |
2J6F |
N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG) BOUND TO CBL-B PEPTIDE |
C |
A |
|
|
 |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7Y |
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2JF9 |
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST |
P |
AC |
|
|
 |
2QPY |
AR LBD with small molecule |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2QR9 |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound |
C |
A |
|
|
 |
2QSE |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP |
C |
A |
|
|
 |
2QXM |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP |
C |
A |
|
|
 |
2QZO |
Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 |
C |
A |
|
|
 |
2R28 |
The complex Structure of Calmodulin Bound to a Calcineurin Peptide |
C |
AB |
EF Hand-like |
|
 |
2V3S |
STRUCTURAL INSIGHTS INTO THE RECOGNITION OF SUBSTRATES AND ACTIVATORS BY THE OSR1 KINASE |
D |
A |
|
|
 |
2VP7 |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2VPB |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2VPE |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
D |
C |
|
|
 |
2VPG |
DECODING OF METHYLATED HISTONE H3 TAIL BY THE PYGO-BCL9 WNT SIGNALING COMPLEX |
B |
A |
|
|
 |
2VZD |
CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA PARVIN IN COMPLEX WITH PAXILLIN LD1 MOTIF |
C |
A |
|
|
 |
2VZG |
CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA-PARVIN IN COMPLEX WITH PAXILLIN LD2 MOTIF |
A |
B |
|
|
 |
2VZI |
CRYSTAL STRUCTURE OF THE C-TERMINAL CALPONIN HOMOLOGY DOMAIN OF ALPHA-PARVIN IN COMPLEX WITH PAXILLIN LD4 MOTIF |
A |
B |
|
|
 |
2W0P |
CRYSTAL STRUCTURE OF THE FILAMIN A REPEAT 21 COMPLEXED WITH THE MIGFILIN PEPTIDE |
C |
AB |
Immunoglobulin-like beta-sandwich |
|
 |
2W73 |
HIGH-RESOLUTION STRUCTURE OF THE COMPLEX BETWEEN CALMODULIN AND A PEPTIDE FROM CALCINEURIN A |
K |
ABF |
|
|
 |
2W9R |
STRUCTURAL BASIS OF N-END RULE SUBSTRATE RECOGNITION IN ESCHERICHIA COLI BY THE CLPAP ADAPTOR PROTEIN CLPS |
B |
A |
|
|
 |
2ZFX |
Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 |
C |
A |
|
|
 |
2ZJD |
Crystal Structure of LC3-p62 complex |
D |
C |
beta-Grasp (ubiquitin-like) |
|
 |
2ZL9 |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLA |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZLC |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMH |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMI |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZMJ |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
2ZXN |
A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket |
C |
A |
|
|
 |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
 |
3BEV |
11mer Structure of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding |
C |
A |
|
|
 |
3BQD |
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CS8 |
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CWD |
Molecular recognition of nitro-fatty acids by PPAR gamma |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3CXW |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I |
B |
A |
|
|
 |
3CY2 |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand II |
B |
A |
|
|
 |
3CY3 |
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and the JNK inhibitor V |
B |
A |
|
|
 |
3D24 |
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3D8C |
Factor inhibiting HIF-1 alpha D201G mutant in complex with ZN(II), alpha-ketoglutarate and HIF-1 alpha 19mer |
B |
A |
|
|
 |
3D9T |
CIAP1-BIR3 in complex with N-terminal peptide from Caspase-9 (ATPFQE) |
C |
A |
Inhibitor of apoptosis (IAP) repeat |
|
 |
3D9U |
The BIR3 domain of cIAP1 in complex with the N terminal peptide from SMAC/DIABLO (AVPIAQ). |
B |
A |
Inhibitor of apoptosis (IAP) repeat |
|
 |
3DCT |
FXR with SRC1 and GW4064 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
3DDA |
Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide |
B |
A |
|
|
 |
3DDB |
Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a substrate analog peptide |
B |
A |
|
|
 |
3DOW |
Complex structure of GABA type A receptor associated protein and its binding epitope on calreticulin |
B |
A |
|
|
 |
3DXC |
Crystal structure of the intracellular domain of human APP in complex with Fe65-PTB2 |
D |
C |
|
|
 |
3DXD |
Crystal structure of the intracellular domain of human APP (T668E mutant) in complex with Fe65-PTB2 |
D |
C |
|
|
 |
3DXE |
Crystal structure of the intracellular domain of human APP (T668A mutant) in complex with Fe65-PTB2 |
B |
A |
|
|
 |
3E7C |
Glucocorticoid Receptor LBD bound to GSK866 |
D |
B |
|
|